ϐ̂ߏiElCLOiwꏊʁjbeEϕi̓AbgRX

ϐ ߏiElCLO

AbgRX > XLPAEbϕi > ϐ > ϐ > lCLO > wꏊ

ϐ

wꏊʃN`R~LO

wꏊʂ̐lCACéH

fp[g

1
CvT / UE^CR ANA
CvT
UE^CR ANA [ϐ]

5.3

N`R~19968

ōiF100mLE2,970~ / 200mlE4,730~ / 300mLE6,050~

F2014/5/23 (2024/10/1lj)

VbsOTCg

2
SK-II / tFCV g[gg GbZX
tFCV g[gg GbZX [ϐEu[X^[Et]

5.6

N`R~33160

ōiF75mlE12,650~ / 160mlE23,100~ / 230mlE29,150~ / -E13,970~ (ҏW)

F1980N12 (2015/7/21lj)

VbsOTCg

3
SHISEIDO / ICf~ GbZX[V
ICf~ GbZX[V [ϐEet]

5.6

N`R~3775

ōiF145ml(tB)E9,130~ / 145mlE9,680~

F2023/3/1

VbsOTCg

fp[gŐlCŐVLO

X[p[EhbO

1
SOFINA iP / pwg[gg bωt
pwg[gg bωt [ϐ]

5.2

N`R~1716

ōiF150mlE1,980~ / 160mlE2,420~ / 300mlE3,630~ / 320mlE3,960~ (ҏW)

F2023/11/4 (2024/9/28lj)

VbsOTCg

2
{ / v~A pZϐ
{
v~A pZϐ [ϐ]

5.1

N`R~2907

ōiF170ml(‚߂)E880~ / 170mlE990~ (ҏW)

F2021/3/16

VbsOTCg

3
i`G / ngMϐ
i`G
ngMϐ [ϐE{fB[VE~N]

5.2

N`R~3394

ōiF500ml (I[vi)

F2022/11/30

VbsOTCg

X[p[EhbOŐlCŐVLO

oGeBVbv

1
Anua / hN_~77 X[WOgi[
hN_~77 X[WOgi[ [ϐ]

5.0

N`R~5308

ōiF250mlE2,380~

F- (2022/4/25lj)

VbsOTCg

2
{g[NX / AvVbg p GtFNg NCXg [V
AvVbg p GtFNg NCXg [V [ϐ]

5.4

N`R~192

ōiF300mLE1,650~

F2024/9/24

VbsOTCg

3
{g[NX / AvVbg CX`[CWO XLg[gg [V
AvVbg CX`[CWO XLg[gg [V [ϐ]

5.0

N`R~262

ōiF300mlE1,320~

F2022/9/28

VbsOTCg

oGeBVbvŐlCŐVLO

ϕiX

1
RXfRe / p }CNo[ [V
p }CNo[ [V [ϐEtFCXICEo[EI[Cϕi]

5.3

N`R~1141

ōiF150mlE3,850~ / 250mlE5,280~

F2024/9/16

VbsOTCg

2
ArI / ArI pXLRfBVi[ GbZV N
ArI
ArI pXLRfBVi[ GbZV N [ϐ]

5.5

N`R~2274

ōiF110mlE3,850~ / 165mlE5,500~ / 330mlE9,350~

F2022/5/17

3
KANEBO / XL@n[iCU[
XL@n[iCU[ [ϐ]

5.1

N`R~2796

ōiF180LE5,500~

F2024/3/8

VbsOTCg

ϕiXŐlCŐVLO

RrjGXXgA

1
Ǖi / ϐEqpEێ^Cv
Ǖi
ϐEqpEێ^Cv [ϐ]

4.8

N`R~11056

ōiF50ml / 200ml / 400ml

F- (2022/9/28lj)

2
Mitea ORGANIC(~eBA I[KjbN) / zCgjOZ[V
zCgjOZ[V [ϐ]

4.8

N`R~138

ōiF120mlE1,991~

F2022/10/4

VbsOTCg

3
Ǖi / ϐEqpEƂ^Cv
Ǖi
ϐEqpEƂ^Cv [ϐ]

4.7

N`R~7285

ōiF50ml / 200ml / 400ml

F- (2022/9/28lj)

RrjGXXgAŐlCŐVLO

ʔ̉ϕiERX

1
CvT / UE^CR ANA
CvT
UE^CR ANA [ϐ]

5.3

N`R~19968

ōiF100mLE2,970~ / 200mlE4,730~ / 300mLE6,050~

F2014/5/23 (2024/10/1lj)

VbsOTCg

2
KANEBO / XL@n[iCU[
XL@n[iCU[ [ϐ]

5.1

N`R~2796

ōiF180LE5,500~

F2024/3/8

VbsOTCg

3
SK-II / tFCV g[gg GbZX
tFCV g[gg GbZX [ϐEu[X^[Et]

5.6

N`R~33160

ōiF75mlE12,650~ / 160mlE23,100~ / 230mlE29,150~ / -E13,970~ (ҏW)

F1980N12 (2015/7/21lj)

VbsOTCg

ʔ̉ϕiERXŐlCŐVLO

1
\eBX / oC^eB[V
oC^eB[V [ϐ]

7.0

N`R~1

ōiF-

F-

2
i[h / I[ZgNCh
i[h
I[ZgNCh [ϐ]

6.0

N`R~2

ōiF-

F-

3
\eBX / \tgjO[V
\tgjO[V [ϐ]

7.0

N`R~2

ōiF-

F-

K̔ŐlCŐVLO

ƗX܁ET

1
GAUDISKIN / Ci[CXgTA[V
Ci[CXgTA[V [ϐ]

5.4

N`R~72

ōiF-

F-

2
Ǖi / NAPAp@胍[V
Ǖi
NAPAp@胍[V [ϐ]

4.7

N`R~153

ōiF50ml / 300ml

F2022/7/13 (2022/9/28lj)

3
Ǖi / pNAPAӂ胍[V
Ǖi
pNAPAӂ胍[V [ϐ]

5.1

N`R~48

ōiF50mL / 270mL / 300mL

F2024/5/29

ƗX܁ETŐlCŐVLO

ڃgsbNX

CɂȂRXLike悤I

ڂ̏tVRXWI

݂Ȃ̐RX́HN`R~܂Ƃ

ŐVv[g

l[~Ol[~O@tbtB[pE_[ubV
蔭FŃi`ɌFUP
N
`
wꏊ
N`R~e

i

ϐ̏iꗗ݂

i
`
N`R~

N`R~

ϐ̃N`R~ꗗ݂

N
`
ߓx
wꏊ